Navigation Links
Health-care eyes focus on San Francisco, war of the stents

The talk of the town (the town being San Francisco, which kicks of the JP Morgan Annual Healthcare Conference on Monday) will most likely be the news from Sunday and early Monday that the Johnson & Johnson acquisition of Guidant for $22 billion is once again no longer a done deal.

On Sunday, Boston Scientific stepped into the fray yet again with its determin......

Full article >>> use of wire mesh to hold open blood vessels and permit increased blood flow in patients who either have occluded or closed vessels (or have them clogged up). In the last few years, the stent business has had further impetus with the incorporation of drugs such as paclitaxel into the stents.

These drugs render the stents more slippery so as not to let particles stick or cling to them. This......

Full article >>> .

Fourteen of the 26 stocks covered in this analysis were above the Dow and the Nasdaq National Market. Twelve declined versus these indices. This means theres a bit of a mixed bag with the tendency to be slightly better on those that outperformed. Some of the best companies had truly great years (particularly Dade-Behring, the leader in performance, and Monsanto).

Abbott spin-of......

Full article >>> d technology news community distributed via the Web, the wireless Web and free daily e-mail newsletters.

The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/09/06


Related biology technology :

1. CIOs focus on the business case while facing authority erosion
2. Biotech officials praise focus of new venture fund
3. NameProtect sold, tech entrepreneur to focus on Jellyfish.com
4. Wisconsins role in health a focus of biotech event
5. Candidates sparring over jobs focuses debate on right issue
6. BarCampMilwaukee promises a tech-focused event
7. Angel fund to focus on women and minority businesses
8. Fusion 2006 symposium focuses on making IT work for businesses
9. Exec focuses on blogs as business tool
10. New UW position focusing on Internet security
11. State of biotech, medical device sector is focus of upcoming conference
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... 23, 2017 /PRNewswire/ - The Fight Against Cancer Innovation ... (OICR) are pleased to report that Fusion Pharmaceuticals Inc. ... Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as ... HealthCap, TPG Biotechnology Partners, and Genesys Capital, as well ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, Inc. ... marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. The ... facilities during periods of rest. A lightweight, non-invasive monitor is placed on the ...
(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , a human ... LLC (KRS) clinical development program. KRS is a neurotechnology spin-out from the ... clinical applications. The terms of the transaction were not disclosed. , It ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
Breaking Biology News(10 mins):